Key Takeaways
- Thousands of cancer patients in Pakistan are experiencing severe pain due to a nationwide shortage of essential opioid medicines.
- The crisis is caused by delays in government approval for import quotas and regulatory clearances.
- Doctors at major hospitals are forced to use less effective alternatives, impacting treatment quality.
Thousands of cancer patients across Pakistan, including children with advanced cancers, are facing severe pain due to a nationwide shortage of essential opioid medicines such as morphine and fentanyl. According to oncologists and hospital pharmacists, the shortage has disrupted treatment at several major cancer hospitals, forcing doctors to rely on less effective painkillers that cannot adequately manage severe cancer pain.
Arif Arain, a senior pharmacist at a Karachi hospital, reported that his facility has already run out of injectable morphine and fentanyl. He added that their remaining stock of oral morphine capsules is expected to be exhausted within days. Morphine and fentanyl are considered the standard treatment for moderate to severe cancer pain and are recommended by the World Health Organization (WHO) for palliative and end-of-life care.
Specialists say patients with advanced cancers, including metastatic breast cancer, pancreatic cancer, bone tumors, head and neck cancers, and childhood cancers, often depend on these medicines for effective pain relief. The shortage is particularly concerning as it affects a vulnerable population that requires specialized medical attention.
Pharmaceutical manufacturers and hospital pharmacists attribute the crisis to delays in government approval of annual import quotas for controlled narcotic raw materials, import permits, and other regulatory clearances. They warned that even if approvals are granted immediately, fresh supplies are unlikely to reach hospitals before October or November.
A senior official from the Ministry of National Health Services stated that the ministry had not been formally informed of a nationwide shortage and added that the matter would be reviewed if such shortages were confirmed. However, this statement has raised concerns among medical professionals who fear that without immediate action, patients will continue to suffer.
The situation highlights the critical need for streamlined regulatory processes and improved communication between government agencies and healthcare providers. Medical experts emphasize that timely approval of import quotas is essential to ensure that cancer patients receive the necessary medications to manage their pain effectively.
In a statement, Arif Arain highlighted the urgency: 'We are running out of these crucial medicines, which means our ability to provide effective pain relief for our patients is severely compromised. This situation must be addressed immediately.'
'We are running out of these crucial medicines, which means our ability to provide effective pain relief for our patients is severely compromised. This situation must be addressed immediately.'
Arif Arain, Senior pharmacist at a Karachi hospital
